Compensatory glomerular growth after unilateral nephrectomy is VEGF dependent

被引:48
作者
Flyvbjerg, A
Schrijvers, BF
De Vriese, AS
Tilton, RG
Rasch, R
机构
[1] Aarhus Univ, Inst Anat, Dept Cell Biol, DK-8000 Aarhus, Denmark
[2] State Univ Ghent Hosp, Dept Internal Med, Renal Unit, B-9000 Ghent, Belgium
[3] Texas Biotechnol Corp, Dept Pharmacol, Houston, TX 77030 USA
[4] Aarhus Univ, Med Dept M, Inst Expt Clin Res, Med Res Labs, DK-8000 Aarhus C, Denmark
来源
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM | 2002年 / 283卷 / 02期
关键词
compensatory renal growth; glomerular volume; insulin-like growth factor I; kidney weight; vascular endothelial growth factor-antibody;
D O I
10.1152/ajpendo.00007.2002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Various growth factors and cytokines have been implicated in different forms of kidney enlargement. Vascular endothelial growth factor (VEGF) is essential for normal renal development and plays a role in diabetic glomerular enlargement. To explore a possible role for VEGF in compensatory renal changes after uninephrectomy, we examined the effect of a neutralizing VEGF-antibody (VEGF-Ab) on glomerular volume and kidney weight in mice treated for 7 days. Serum and kidney insulin-like growth factor I (IGF-I) levels were measured, since IGF-I has been implicated in the pathogenesis of compensatory renal growth, and VEGF has been suggested to be a downstream mediator of IGF-I. Placebo-treated uninephrectomized mice displayed an early transient increase in kidney IGF-I concentration and an increase in glomerular volume and kidney weight. In VEGF-Ab-treated uninephrectomized animals, increased glomerular volume was abolished, whereas renal hypertrophy was partially blocked. Furthermore, the renal effects of VEGF-Ab administration were seen without affecting the renal IGF-I levels. In conclusion, these results demonstrate that compensatory glomerular growth after uninephrectomy is VEGF dependent.
引用
收藏
页码:E362 / E366
页数:5
相关论文
共 32 条
[1]   Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele [J].
Carmeliet, P ;
Ferreira, V ;
Breier, G ;
Pollefeyt, S ;
Kieckens, L ;
Gertsenstein, M ;
Fahrig, M ;
Vandenhoeck, A ;
Harpal, K ;
Eberhardt, C ;
Declercq, C ;
Pawling, J ;
Moons, L ;
Collen, D ;
Risau, W ;
Nagy, A .
NATURE, 1996, 380 (6573) :435-439
[2]   DIETARY PROTEIN-INDUCED RENAL GROWTH - CORRELATION BETWEEN RENAL IGF-I SYNTHESIS AND HYPERPLASIA [J].
CHIN, E ;
BONDY, CA .
AMERICAN JOURNAL OF PHYSIOLOGY, 1994, 266 (04) :C1037-C1045
[3]   Increased renal expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in experimental diabetes [J].
Cooper, ME ;
Vranes, D ;
Youssef, S ;
Stacker, SA ;
Cox, AJ ;
Rizkalla, B ;
Casley, DJ ;
Bach, LA ;
Kelly, DJ ;
Gilbert, RE .
DIABETES, 1999, 48 (11) :2229-2239
[4]  
De Vriese A, 2001, J AM SOC NEPHROL, V12, P993, DOI 10.1681/ASN.V125993
[5]   TISSUE CONCENTRATIONS OF SOMATOMEDIN-C - FURTHER EVIDENCE FOR MULTIPLE SITES OF SYNTHESIS AND PARACRINE OR AUTOCRINE MECHANISMS OF ACTION [J].
DERCOLE, AJ ;
STILES, AD ;
UNDERWOOD, LE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1984, 81 (03) :935-939
[6]   THE VASCULAR ENDOTHELIAL GROWTH-FACTOR FAMILY OF POLYPEPTIDES [J].
FERRARA, N ;
HOUCK, KA ;
JAKEMAN, LB ;
WINER, J ;
LEUNG, DW .
JOURNAL OF CELLULAR BIOCHEMISTRY, 1991, 47 (03) :211-218
[7]   Putative pathophysiological role of growth factors and cytokines in experimental diabetic kidney disease [J].
Flyvbjerg, A .
DIABETOLOGIA, 2000, 43 (10) :1205-1223
[8]   OCTREOTIDE ADMINISTRATION IN DIABETIC RATS - EFFECTS ON RENAL HYPERTROPHY AND URINARY ALBUMIN EXCRETION [J].
FLYVBJERG, A ;
MARSHALL, SM ;
FRYSTYK, J ;
HANSEN, KW ;
HARRIS, AG ;
ORSKOV, H .
KIDNEY INTERNATIONAL, 1992, 41 (04) :805-812
[9]   Compensatory renal growth in uninephrectomized adult mice is growth hormone dependent [J].
Flyvbjerg, A ;
Bennett, WF ;
Rasch, R ;
van Neck, JW ;
Groffen, CAH ;
Kopchick, JJ ;
Scarlett, JA .
KIDNEY INTERNATIONAL, 1999, 56 (06) :2048-2054
[10]   Inhibitory effect of a growth hormone receptor antagonist (G120K-PEG) on renal enlargement, glomerular hypertrophy, and urinary albumin excretion in experimental diabetes in mice [J].
Flyvbjerg, A ;
Bennett, WF ;
Rasch, R ;
Kopchick, JJ ;
Scarlett, JA .
DIABETES, 1999, 48 (02) :377-382